Diagnosis of Obstructive Sleep Apnea

Diagnostic Approach

The American Academy of Sleep Medicine recommends that polysomnography (PSG) is the gold standard for diagnosing OSA in adults, though home sleep apnea testing (HSAT) is acceptable for uncomplicated patients at high risk for moderate-to-severe disease 1, 2
Diagnostic testing must be performed in conjunction with a comprehensive sleep evaluation that identifies excessive daytime sleepiness, habitual loud snoring, witnessed apneas, gasping, or choking episodes, and diagnosed hypertension as important risk factors 1, 3, 4
The American Academy of Sleep Medicine suggests that questionnaires, clinical tools, or prediction algorithms alone should not be used to diagnose OSA due to low diagnostic accuracy and high risk of misclassification 1, 2, 5

For uncomplicated patients at high risk, the American Academy of Sleep Medicine recommends using either PSG or HSAT when patients have excessive daytime sleepiness and at least 2 of the following: habitual loud snoring, witnessed apnea/gasping, or diagnosed hypertension 1, 2, 4
HSAT technical requirements include minimum sensors such as nasal pressure, chest/abdominal respiratory inductance plethysmography, and oximetry, and must be administered by an AASM-accredited sleep center under board-certified sleep medicine physician supervision 3, 4, 5

The American Academy of Sleep Medicine recommends using in-laboratory PSG when patients have significant cardiorespiratory disease, potential respiratory muscle weakness from neuromuscular conditions, awake hypoventilation or suspected sleep-related hypoventilation, chronic opioid medication use, history of stroke, or severe insomnia 1, 2, 4, 6

OSA is diagnosed when the Apnea-Hypopnea Index (AHI) is ≥5 events/hour with associated symptoms, or ≥15 events/hour regardless of symptoms, according to the American Academy of Sleep Medicine 7
The severity of OSA can be classified based on AHI or Respiratory Disturbance Index (RDI) as mild (AHI/RDI ≥5 and <15 events/hour), moderate (AHI/RDI ≥15 and ≤30 events/hour), or severe (AHI/RDI >30 events/hour) 7

HSAT underestimates OSA severity by 10-26% compared to PSG, and should not be used for general screening without knowledge of sleep-related history and complaints, or in patients with comorbid conditions where evidence is insufficient, as stated by the American Academy of Sleep Medicine 5
Nocturnal pulse oximetry alone has 85-94% sensitivity for moderate-to-severe OSA but cannot distinguish obstructive from central sleep apnea and should not replace definitive testing, according to the American Academy of Sleep Medicine 3

Polysomnography (PSG) performed in an AASM‑accredited sleep laboratory under the supervision of a board‑certified sleep physician is the gold standard for diagnosing obstructive sleep apnea in adults and should be combined with a comprehensive sleep evaluation. Strong recommendation – American Academy of Sleep Medicine 8, 9
Clinical screening tools and questionnaires (e.g., STOP‑BANG) must not be used alone to diagnose OSA because of low diagnostic accuracy and a high risk of misclassification. Strong recommendation – American Academy of Sleep Medicine 8, 9

PSG is mandatory for patients with any of the following:
Strong recommendation – American Academy of Sleep Medicine 8, 9

HSAT with a technically adequate device may be employed for uncomplicated adult patients who show signs and symptoms suggesting a moderate‑to‑severe OSA risk. This includes individuals with excessive daytime sleepiness plus at least two of: habitual loud snoring, witnessed apneas/gasping/choking, or diagnosed hypertension. Strong recommendation – American Academy of Sleep Medicine 8, 9, 10

If a single HSAT result is negative, inconclusive, or technically inadequate, a full‑night PSG must be performed because HSAT cannot reliably detect arousal‑based respiratory events and has a high false‑negative rate. Strong recommendation – American Academy of Sleep Medicine 8, 9
When an initial PSG is negative but clinical suspicion for OSA remains high, a second PSG may be considered to account for night‑to‑night variability. Weak recommendation – American Academy of Sleep Medicine 8, 9

A split‑night protocol (diagnostic portion followed by CPAP titration in the same night) may be used instead of a full‑night PSG when clinically appropriate. Weak recommendation – American Academy of Sleep Medicine 8, 9
Criteria for employing a split‑night protocol include: